Managing Subdural Bleeding Associated With Rivaroxaban: A Series of 3 Cases

Journal of Pharmacy Practice
Andrew C FaustTina Harrach Denetclaw

Abstract

To report 3 cases of subdural bleeding associated with rivaroxaban managed by 3-factor prothrombin complex concentrate (PCC3). Case 1 presented with a 1-cm thick subdural hematoma (SDH) 12 hours after her last dose of rivaroxaban. Case 2 presented with a right 1-cm acute right SDH with 2 to 3 mm of midline shift 24 hours after his last dose of rivaroxaban. Case 3 presented with a 1.8-cm thick right cerebral convexity hematoma 12 hours after her last dose of rivaroxaban. All patients received 23 to 35 units/kg PCC3 with 1 to 3 units of fresh frozen plasm (FFP) and demonstrated no progression in lesions measured by repeat computed tomography (CT). Two patients were discharged to rehabilitation facilities and 1 patient ultimately died due to the location of the lesion. Rivaroxaban has no specific antidote. Current bleeding management strategies are based on expert opinion. The risks and benefits for differing strategies are unclear, and no clinical experience has been reported to date. These cases begin to illuminate differences among choices for managing bleeding associated with Xa inhibitors. In this case series, 25 to 35 units/kilogram PCC3 and FFP 1 to 3 units ceased rivaroxaban-associated bleeding without thrombogenic complic...Continue Reading

References

Jan 1, 1985·Comparative Biochemistry and Physiology. A, Comparative Physiology·J H LewisJ Gavaler
Nov 25, 2005·Stroke; a Journal of Cerebral Circulation·Joshua N GoldsteinJonathan Rosand
May 16, 2008·The New England Journal of Medicine·Stephan A MayerUNKNOWN FAST Trial Investigators
Jun 10, 2011·Thrombosis and Haemostasis·Helen ManiEdelgard Lindhoff-Last
Apr 5, 2012·American Journal of Hematology·Scott KaatzJack Ansell
May 3, 2013·Thrombosis and Haemostasis·Elisabeth PerzbornVolker Laux
Sep 4, 2013·Clinical Pharmacokinetics·Wolfgang MueckMichael Becka
Jan 5, 2014·Blood·Deborah M SiegalMark A Crowther

❮ Previous
Next ❯

Citations

May 5, 2017·Journal of Pharmacy Practice·Sanjay MohanMark K Su
Jun 11, 2019·International Journal of Emergency Medicine·Maureane HoffmanJerrold H Levy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Lisa E DumkowDouglas L Jennings
Journal of Computer Assisted Tomography
S TantanaA Luisiri
© 2022 Meta ULC. All rights reserved